SWORD Health, a digital musculoskeletal (MSK) solution, raised $163 million in a Series D funding round led by Sapphire Ventures with participation from new investors Sozo Ventures, Willoughby Capital, ADQ and Localglobe, and General Catalyst, Khosla Ventures, Founders Fund, Bond, Transformation Capital, and Green Innovations. This brings the total primary and secondary transactions to more than $320M invested in SWORD, with the current round valued at $1.8B, catapulting it to healthtech unicorn status. The primary funding round of $163M was heavily oversubscribed, resulting in investors purchasing an additional $26M, in a secondary transaction which propelled the valuation to $2B. Read more.
SWORD Health Raises $163M in D Round
